Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments

Authors

Publication Details

Journal
Neurology Neuroimmunology & Neuroinflammation
Published
2026-04-06
DOI
https://doi.org/10.1212/nxi.0000000000200583
Citations
1
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
20.70
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments

Danielle Kei Pua, João Vitor Mahler, Sathya Narasimhan, Farrah Jasmine Mateen et al.
1 citations
Neurology Neuroimmunology & Neuroinflammation
Multiple Sclerosis Research Studies
20.70
article

Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments

Danielle Kei Pua, João Vitor Mahler, Sathya Narasimhan, Farrah Jasmine Mateen, Mulan Jiang, Avanteeka Ganguly, Mattia Wruble Clark, Jenna Bernice Harowitz, Michael Levy, Philippe A. Bilodeau, Brian C. Healy, Shamik Bhattacharyya
article en
1 citations

Abstract

No abstract available for this paper.
Neurology Neuroimmunology & NeuroinflammationVol. 13(3)
Good health and well-being
Openalex Percentile: Top 1%
Multiple Sclerosis Research Studies
20.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments — Danielle Kei Pua, João Vitor Mahler, et al. · Neurology Neuroimmunology & Neuroinflammation (2026) | TGRS Research Map | TGRS